Leriglitazone Uses, Dosage, Side Effects and more

Leriglitazone is under investigation in clinical trial NCT03917225 (A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients).

Trade Name Leriglitazone
Generic Leriglitazone
Leriglitazone Other Names Leriglitazone
Type
Formula C19H20N2O4S
Weight Average: 372.438
Monoisotopic: 372.114377828
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share